lobbying_activities: 1733590

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1733590	50d58cc8-6b91-4402-9033-a5f6606e9d89	Q3	RED+BLUE STRATEGIES	400693064	COHERUS BIOSCIENCES	2015	third_quarter	PHA	CMS Proposed Physician Fee Schedule(PFS) with a focus on provisions dealthing with the treatment of Medicare's reimbursement for a new class of prescription medications, Biosimilars. Education and advocacy related to what elements are necessary to ensure a hospitable environment to grow the new Biosimilars market in the United States.	Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE	20000		0	0	2015-10-16T11:32:18.847000-04:00